BDO Wealth Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-400
Closed -$1K 987
2020
Q2
$1K Sell
400
-400
-50% -$1.44K ﹤0.01% 681
2020
Q1
$3K Buy
800
+50
+7% +$165 ﹤0.01% 661
2019
Q4
$2K Buy
+750
New +$1.95K ﹤0.01% 564

Other funds holding BMY.RT

BDO Wealth Advisors's BMY.RT Position: Q3 2020 in Review

BDO Wealth Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q3 2020, closing a stake of 400 shares — an estimated $1K sold.

BDO Wealth Advisors first reported a position in BMY.RT in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q1 2020. 571 funds tracked by Wall St. Rank hold BMY.RT as of Q3 2020.

  • BDO Wealth Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q3 2020 after selling out during the quarter.
  • BDO Wealth Advisors sold 400 Bristol-Myers Squibb Company Contingent Value Rights shares in Q3 2020, an estimated $1K.
  • BDO Wealth Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 3 quarters.
  • BDO Wealth Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3K in Q1 2020.
  • 571 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q3 2020.

Based on BDO Wealth Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.